PAR-25-229-Full-Announcement.html

This document is a full announcement for the Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) federal grant opportunity.

The purpose of this funding opportunity is to support a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to basic or clinical genomic science and broadly applicable to human health and disease. This includes developing innovative analytical methodologies and approaches, early-stage tool and software development, and refinement of high-value software and tools for the biomedical genomics community. All proposed work should address scalability to handle increasingly larger datasets.

The funding instrument is an R21 grant, and eligible applicants include non-profits, tribal governments, higher education institutions, for-profit organizations, and state/local governments, among others. This grant opportunity is assigned to the Medical Library Assistance (CFDA 93.879) and Human Genome Research (CFDA 93.172) federal grant programs, administered by the Department of Health and Human Services' National Institutes of Health.